medigraphic.com
ISSN 0028-3851 (Print)

2006, Number 1

Next >>

Rev Neurol Neurocir Psiquiat 2006; 39 (1)

Cigarette smoking among migraineur patients: a systematic review

Campo-Arias A, Rueda-Sánchez M, Díaz-Martínez LA

Language: Spanish
References: 30
Page: 1-6
PDF size: 53.04 Kb.


ABSTRACT

Migraine sufferers present a high risk for substance dependence; however, we do not know accurately the prevalence of smoking among patients with migraine. The objective of this review was to establish the prevalence of cigarette smoking in migraineurs. A systematic review was carried out in Ebsco, Embase, Lilacs, Ovid, Proquest, and PubMed databases. Nineteen articles were found, but just eleven of them met inclusion criteria. The mean lifetime prevalence of cigarette smoking was 65.1%, the mean current prevalence was 47.8%, and the current prevalence of nicotine dependence was 32.8%. It concludes that cigarette smoking is rather high in patients with migraine; however it is not quite clear the possible association between migraine and cigarette smoking.


REFERENCES

  1. Dahlöf CGH, Linton-Dalhöf P, Laínez JM, Pascual J. ¿La migraña es una enfermedad cerebral progresiva? Neurología 2005; 20: 356-65.

  2. Ierasalimschy R, Ferreira P. Fatores desencadeantes de crises de migrânea em pacientes com migrânea sem aura. Arq Neuropsiquiatr 2002; 60(3A): 609-13.

  3. Gilman SE, Abrams DB, Buka SL. Socioeconomic status over the life course and stages of cigarette use: initiation, regular use, and cessation. J Epidemiol Com Health 2003; 57: 802-8.

  4. Breslau N, Davis GC. Migraine, physical health and psychiatric disorders: a prospective epidemiologic study in young adults. J Psychiatr Res 1993; 27: 211-21.

  5. Payne TJ, Stetson B, Stevens VM, Johnson CA, Penzien DB, Van Dorsten B. The impact of cigarette smoking on headache activity in headache patients. Headache 1991; 31: 329-32.

  6. Levi R, Edman GV, Ekborn K, Waldenlind E. Episodic cluster headache II: high tobacco and alcohol consumption in males. Headache 1992; 32: 184-7.

  7. Aromaa M, Sillanpaa M, Rautava P, Helenius H. Prevalence of frequent headache in young Finish adults starting a family. Cephalalgia 1993; 13: 330-7.

  8. Russell MB, Rasmussen BK, Fenger K, Olesen J. Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 1996; 16: 239-45.

  9. Mannix LK, Frame JR, Solomon GD. Alcohol, smoking, and caffeine use among headache patients. Headache 1997; 37: 572-6.

  10. Chabriat H, Danchot J, Michel P, Joire JE, Henry P. Precipitating factors of headache. A prospective study in a national control-matched survey in migraineurs and nonmigraineurs. Headache 1999; 39: 335-8.

  11. Spiering ELH, Ranke AH, Honkoop PC. Precipitating and aggravating factors of migraine versus tension-type headache. Headache 2001; 41: 554-8.

  12. Olive JM, González-Menacho J. Tobacco brand-related headache. Neurología 2002; 8: 438-42.

  13. Volans GN, Castleden CM. The relationship between smoking and migraine. Postgrad Med J 1976; 52: 80-2.

  14. Manzoni GC, Terzano MG, Bono G, Miciele G, Martucci N, Nap-pi G. Cluster headache clinical findings in 180 patients. Cephalalgia 1983; 3: 21-30.

  15. Littlewood JT, Glover V, Sandler M, Petty R, Peatfield R, Clif-ford-Rose F. Migraine and cluster headache: links between platelet monoamine oxidase activity, smoking and personality. Headache 1984; 24: 30-4.

  16. Chen TC, Leviton A, Edelstein S, Ellenberg JH. Migraine and other diseases in women of reproductive age. The influence of smoking on observed association. Arch Neurol 1987; 44: 1024-8.

  17. Hannerz J. Symptoms and diseases and smoking habits in female episodic cluster headache and migraine patients. Cephalalgia 1997; 17: 499-500.

  18. Breslau N. Psychiatric comorbidity in migraine. Cephalalgia 1998; 18(Suppl. 22): 56-61.

  19. Ulrich V, Olesen J, Gervil M, Russell MB. Possible risk factor and precipitants for migraine with aura in discordant twin-pairs: a population-based study. Cephalalgia 2000; 20: 821-5.

  20. Vlajinac H, Sipetic S, Dzoljic E, Maksimovic J, Marinkovic J, Kostic V. Some lifestyle habits of female Belgrade university students with migraine and non-migraine primary headache. J Headache Pain 2003; 4: 67-71.

  21. Çelik Y, Ekuklu G, Tokuç B, Utku U. Migraine prevalence and some related factors in Turkey. Headache 2005; 45: 32-6.

  22. Rasmussen BK. Migraine and tension-type headache in a gen-eral population: precipitating factors, female hormones, sleep pattern and relation lifestyle. Pain 1993; 53: 65-72.

  23. Takeshima T, Ishizaki K, Fukuhara Y, et al. Population-based door to-door survey of migraine in Japan: The Daisen Study. Headache 2004; 44: 8-19.

  24. Lassen LH, Ashina M, Christiansen I, Olesen J. Nitric oxide synthase inhibition in migraine. Lancet 1997; 349: 401-2.

  25. Hudson JI, Mangweth B, Pope HG, De Col C, Hausmann A, Gutweniger S, et al. Family study of affective spectrum disorder. Arch Gen Psychiatry 2003; 60: 170-7.

  26. Broadley AJM, Korszun A, Jones CJH, Frenneaux MP. Arterial endothelial functions is impaired I treated depression. Heart 2002; 88: 521-4.

  27. DeVane CL, Nemeroff CB. Guide to psychotropic drug interactions. New York: MBL Communications Inc, 1998: 12-38.

  28. Fowler JS, Volkow ND, Wang G-J, Pappas N, Logan J, MacGregor R, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996; 379: 733-6.

  29. Cady R, Dodick D. Diagnosis and treatment of migraine. Mayo Clin Proc 2002; 77: 255-61.

  30. Chang CL, Donaghy M, Poulter, World Health Organization Col-laborative study of cardiovascular disease and steroid hormone contraception. BMJ 1999; 318: 13-8.




2020     |     www.medigraphic.com